Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,064,145 papers from all fields of science
Search
Sign In
Create Free Account
umirolimus
Known as:
40-O-(2-ethoxyethyl)rapamycin
, 42-O-(2-ethoxyethyl) rapamycin
, rapamycin, 42-O-(2-ethoxyethyl)-
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Broader (3)
Anti-Inflammatory Agents
Immunosuppressive Agents
Sirolimus
Narrower (1)
Biolimus A9
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2020
Highly Cited
2020
Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk.
S. Windecker
,
A. Latib
,
+29 authors
G. Stone
New England Journal of Medicine
2020
Corpus ID: 211100964
BACKGROUND Polymer-free drug-coated stents provide superior clinical outcomes to bare-metal stents in patients at high bleeding…
Expand
2017
2017
Comparison of Biolimus Versus Everolimus for Drug-Eluting Stents in the Percutaneous Treatment of Infra-Inguinal Arterial Disease.
A. Giordano
,
P. Ferraro
,
+10 authors
G. Biondi‐Zoccai
Current Vascular Pharmacology
2017
Corpus ID: 43137570
BACKGROUND Drug-eluting stents (DES) are now considered the most promising device to treat peripheral artery disease (PAD) and…
Expand
2016
2016
Bare metal stenty na cestě dinosaurů: studie LEADERS FREE
I. Varvařovský
2016
Corpus ID: 114161069
Randomizovana, dvojitě zaslepena studie srovnala použiti kovoveho (BMS) a bezpolymeroveho lekoveho stentu (DES) při lecbě nemocn…
Expand
Highly Cited
2015
Highly Cited
2015
Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk.
P. Urban
,
I. Meredith
,
+19 authors
M. Morice
New England Journal of Medicine
2015
Corpus ID: 205097997
BACKGROUND Patients at high risk for bleeding who undergo percutaneous coronary intervention (PCI) often receive bare-metal…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE